Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
Phase I study of Pazopanib (PAZ) in Hepatocellular Carcinoma (HCC): evaluation of clinical activity, Pharmacokinetics (PK), and Dynamic Contrast Enhanced MRI (DCE-MRI) Proceeding/Conference:European Journal of Cancer Supplements | 2009 | ||
A phase I study of pazopanib in patients with advanced hepatocellular carcinoma Proceeding/Conference:Journal of Clinical Oncology | 2009 |